Comparative Evaluation of [18F]5-Fluoroaminosuberic Acid and (4S)-4-3-[18F]fluoropropyl)-l-Glutamate as System 
–Targeting Radiopharmaceuticals
Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication December 5, 2022
- Revision received March 21, 2023
- Published online August 1, 2023.
Article Versions
- previous version (April 28, 2023 - 06:08).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Milena Colovic1,2,
- Hua Yang1,
- Lily Southcott1,
- Helen Merkens2,
- Nadine Colpo2,
- Francois Bénard2,3 and
- Paul Schaffer1,3,4
- 1Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada;
- 2Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada;
- 3Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada; and
- 4Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, Canada
- For correspondence or reprints, contact Paul Schaffer (pschaffer{at}triumf.ca).
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Comparative Evaluation of [18F]5-Fluoroaminosuberic Acid and (4S)-4-3-[18F]fluoropropyl)-l-Glutamate as System –Targeting Radiopharmaceuticals
Jump to section
Related Articles
Cited By...
- No citing articles found.